Search results
Results from the WOW.Com Content Network
The stock of Puma SE (OTCPK:PUMSY, 30-year Financials) appears to be significantly overvalued, according to GuruFocus Value calculation.
Puma Biotech (PBYI) incurs wider loss in Q2. Sales of Nerlynx improve from first-quarter levels. Stock rises 23%.
Puma SE is a German multinational corporation which designs and manufactures athletic and casual footwear, apparel, and accessories, headquartered in Herzogenaurach, Bavaria, Germany. Puma is the third largest sportswear manufacturer in the world. [8] The company was founded in 1948 by Rudolf Dassler (1898–1974).
For premium support please call: 800-290-4726 more ways to reach us
The company was started as M and M Sports in 1987 by Mark Ellis and Martin Churchward. [5]Following a buy-out by private equity group ECI Partners in 2004 the company’s identity changed to MandM Direct in order to reflect their move into selling fashion and lifestyle brands.
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. [2] This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. [2]
Puma Biotech (PBYI) betters loss estimates in Q3. However, its only marketed drug, Nerlynx, disappoints with low sequential growth and as a result, shares take a hit.
German fashion is known for unconventional young designers and manufacturers of sports and outdoor clothing, ready-to-wear and custom-made creations. [ 1 ] Berlin , the country's capital city, is also a fashion capital of the world and the home of Berlin Fashion Week , the country's main event where young and creative German fashion designers ...